Literature DB >> 19577355

Optimizing the approach for lymph node dissection during laparoscopic radical cystectomy.

Ahmed Ghazi1, Reinhold Zimmermann, Amjad Al-Bodour, Alexander Shefler, Gunter Janetschek.   

Abstract

BACKGROUND: Lymph node dissection (LND) for muscle-invasive bladder cancer is one of the integral steps of radical cystectomy. In addition to staging, adequate LND has been found to alter both the prognosis for and the course of the disease after radical cystectomy.
OBJECTIVE: To point out several essential steps that provide optimal exposure for LND during laparoscopic radical cystectomy for muscle-invasive bladder cancer. DESIGN, SETTING AND PARTICIPANTS: From August 2006 to September 2008, we performed 10 laparoscopic cystectomies with an extended LND using this approach at our institution. Patient and tumor characteristics, the anatomic extent of the LND, the number of lymph nodes examined, and the postoperative complications encountered were evaluated. SURGICAL PROCEDURE: Essential steps include (1) a modified five-trocar arrangement; (2) use of a 30 degrees telescope during LND; (3) prior complete mobilization of the sigmoid colon, allowing its retraction using an umbilical tape; (4) accomplishment of most of the bilateral LND from the right side; and (5) performance of LND after removal of the specimen. MEASUREMENTS: The primary end points were adequate intraoperative exposure of the template and number of lymph nodes retrieved. The secondary end point was evaluation of postoperative lymph node recurrence as an assessment of a complete LND. RESULTS AND LIMITATIONS: Mean total operative time was 512.5 min (range: 420-660), with a mean operative time of 143 min (range: 115-165) for the extended LND. Adequate exposure was successful in all 10 patients. The average number of lymph nodes examined was 25.5 (range: 19-32), with 4 nodes positive for metastasis. No patients had pelvic or lymph node metastasis at a mean follow-up of 14.8 mo (range: 4-30). Limitations included an analysis of a small series of patients.
CONCLUSIONS: This new approach provides optimal exposure for an adequate laparoscopic LND during radical cystectomy, without any compromise.

Entities:  

Mesh:

Year:  2009        PMID: 19577355     DOI: 10.1016/j.eururo.2009.06.024

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  6 in total

Review 1.  [Lymphadenectomy for bladder cancer: current status and controversies].

Authors:  T Metzger; G N Thalmann; P Zehnder
Journal:  Urologe A       Date:  2012-03       Impact factor: 0.639

2.  Laparoscopic radical cystectomy with extracorporeal ileal neobladder for muscle-invasive urothelial carcinoma of the bladder: technique and short-term outcomes.

Authors:  Christopher Springer; Nasreldin Mohammed; Stefano Alba; Gerit Theil; Vincenzo Maria Altieri; Paolo Fornara; Francesco Greco
Journal:  World J Urol       Date:  2013-07-02       Impact factor: 4.226

3.  Higher nodal yield with robot-assisted pelvic lymph node dissection for bladder cancer compared to laparoscopic dissection: implications for more accurate staging.

Authors:  Amandeep Arora; Felipe Pugliesi; Ahmed S Zugail; Marco Moschini; Cristiano Pazeto; Petr Macek; Armando Stabile; Camille Lanz; Nathalie Cathala; Mostefa Bennamoun; Rafael Sanchez-Salas; Xavier Cathelineau
Journal:  Arab J Urol       Date:  2020-10-01

4.  Extended pelvic lymph node dissection: before or after radical cystectomy? A multicenter study of the Turkish society of urooncology.

Authors:  Haluk Ozen; Ozgur Ugurlu; Sumer Baltaci; Oztug Adsan; Guven Aslan; Cavit Can; Gurhan Gunaydin; Atilla Elhan; Yasar Beduk
Journal:  Korean J Urol       Date:  2012-07-19

Review 5.  Laparoscopic radical cystectomy.

Authors:  Amr Fergany
Journal:  Arab J Urol       Date:  2012-02-20

Review 6.  Laparoscopic versus open radical cystectomy in bladder cancer: a systematic review and meta-analysis of comparative studies.

Authors:  Kun Tang; Heng Li; Ding Xia; Zhiquan Hu; Qianyuan Zhuang; Jihong Liu; Hua Xu; Zhangqun Ye
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.